3,621 Shares in Kewaunee Scientific Co. (NASDAQ:KEQU) Bought by Barclays PLC

Barclays PLC acquired a new position in Kewaunee Scientific Co. (NASDAQ:KEQU) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 3,621 shares of the technology company’s stock, valued at approximately $121,000. Barclays PLC owned approximately 0.13% of Kewaunee Scientific as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Heron Bay Capital Management purchased a new stake in shares of Kewaunee Scientific in the second quarter worth $252,000. State Street Corp purchased a new stake in shares of Kewaunee Scientific in the third quarter worth $266,000. Ritholtz Wealth Management raised its position in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after buying an additional 2,156 shares in the last quarter. De Lisle Partners LLP raised its position in shares of Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after buying an additional 11,511 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Kewaunee Scientific by 13.4% in the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after buying an additional 10,580 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Insider Activity at Kewaunee Scientific

In other news, CEO Thomas David Hull III sold 2,000 shares of the firm’s stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00. Following the transaction, the chief executive officer now directly owns 42,497 shares of the company’s stock, valued at approximately $2,677,735.97. This trade represents a 4.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Douglas J. Batdorff sold 3,470 shares of the firm’s stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $65.50, for a total value of $227,285.00. Following the transaction, the vice president now directly owns 5,000 shares in the company, valued at $327,500. This trade represents a 40.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 9,369 shares of company stock valued at $572,751 over the last 90 days. 14.20% of the stock is owned by insiders.

Analyst Ratings Changes

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Kewaunee Scientific Stock Up 0.3 %

KEQU opened at $61.28 on Thursday. The stock has a market cap of $176.00 million, a PE ratio of 9.71 and a beta of 0.72. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $67.20. The business’s fifty day simple moving average is $46.78 and its 200 day simple moving average is $44.52.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.